Among the biomarkers related to CKD–MBD, fibroblast growth factor-23 (FGF-23), osteoprotegerin (OPG), calcium, phosphate, and parathyroid hormone (PTH) have been extensively studied. This evidence concerns the gene TNFRSF11B and Marchiafava-Bignami disease.